Exercise oncology from diagnosis to treatment: An overview of outcomes and considerations
Document Type
Book Chapter
Publication Title
Exercise Oncology
Publisher
Springer
School
Exercise Medicine Research Institute
RAS ID
32146
Abstract
Cancer patients and survivors experience wide-ranging acute and persistent toxicities that have implications to reduced physical function, cardiovascular and metabolic complications, musculoskeletal health and quality of life. Over the past several years, the field of exercise oncology has demonstrated a number of opportunities for the use of exercise as a medicine to preserve function and ameliorate and reverse a range of treatment-related adverse effects in patients with cancer receiving treatment. Numerous randomized controlled trials have evolved from early study reports on symptom controls to more contemporary trials investigating clinical and disease-specific endpoints. In this chapter, we provide a brief overview of common cancer treatments and adverse effects and examples of early to contemporary exercise oncology studies including those from pretreatment to during treatment phases examining a range of outcomes and provide considerations and future opportunities in this well-established and yet continuing area of research growth in exercise oncology. As the field continues to evolve in its breath, scope and rigour, future large definitive trials will provide more conclusive information on the role of exercise and its impact on disease progression and cancer-specific and overall survival.
DOI
10.1007/978-3-030-42011-6_5
Access Rights
subscription content
Comments
Fairman, C. M., & Galvão, D. A. (2020). Exercise oncology from diagnosis to treatment: An overview of outcomes and considerations. In K. H. Schmitz (Ed.), Exercise Oncology (pp. 87-110). Springer, Cham. https://doi.org/10.1007/978-3-030-42011-6_5